| Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study | |
| Li, Junjie; Shao, Zhimin; Xu, Binghe; Jiang, Zefei; Cui, Shude; Zhang, Jin; Liao, Ning; Jiang, Jun; Wang, Yongsheng; Ouyang, Quchang | |
| 刊名 | MEDICINE
 |
| 2018 | |
| 卷号 | 97期号:21 |
| 关键词 | adjuvant therapy breast cancer HER2-targeted therapy neoadjuvant therapy trastuzumab |
| ISSN号 | 0025-7974 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3605633 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Li, Junjie,Shao, Zhimin,Xu, Binghe,et al. Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study[J]. MEDICINE,2018,97(21). |
| APA | Li, Junjie.,Shao, Zhimin.,Xu, Binghe.,Jiang, Zefei.,Cui, Shude.,...&Ying, Ziwei.(2018).Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study.MEDICINE,97(21). |
| MLA | Li, Junjie,et al."Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study".MEDICINE 97.21(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论